ADmit Therapeutics S.L.

Description

ADmit Therapeutics S.L. is a frontier-technology company operating from Carretera Laurea Miro 48, Spain. Its cited profile explains that it develops an epigenetic blood test for early Alzheimer's detection using next-generation sequencing to aid diagnosis and accelerate drug discovery. The official website describes aDmit THERAPEUTICS - un test de diagnóstico precoz para la enfermedad de Alzheimer. DETECCIÓN EN LA PRÁCTICA CLÍNICA. ADmit Therapeutics, S.L. es una compañía centrada en el desarrollo y comercialización de una nueva tecnología para la detección precoz de la enfermedad de Alzheimer. The.

Related

• Eli Lilly ($LLY)Indianapolis-headquartered pharmaceutical giant; one of the most valuable US biotechs.
• DIAMFABDIAMFAB is a frontier-technology company operating from Fontaine, France.
• Synapsis LabsSynapsis Labs is a frontier-technology company operating from Koropi, Greece.
• QARNOT COMPUTING SASQarnot Computing SAS is a frontier-technology company operating from 40 Rue Barbès, France.
• Energy Dome SPAEnergy Dome SPA is a frontier-technology company operating from 20158, Italy.
• Spanish National Cancer Research CentreSpanish National Cancer Research Centre is a research or innovation institution operating from Madrid, Spain.
• BioArctic ABDevelops disease-modifying treatments and research programs for neurodegenerative disorders, specifically focusing on Alzheimer’s disease…
• IsentroniqIsentroniq is a frontier-technology company operating from Saint-Germain-En-Laye, France.
• Nexstim OyjNexstim is a Finnish medical-technology company focused on navigated transcranial magnetic stimulation for brain diagnostics and therapy.
• METHINKS SOFTWARE S.LBuilds AI software that detects large vessel occlusions and hemorrhages on non-contrast CT scans; used by stroke teams and hospitals to…
• KeysomKeysom is a frontier-technology company operating from Blésignac, France.
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.